The traditional model for the pharmaceutical industry has focused on the development of blockbuster, broad-spectrum medicines that treat millions of patients globally. However...

Cell culture processes are complex and highly variable, and yet only a handful of key parameters are typically controlled in real time. Critical process parameters and key performance...

With the rising demand of gene therapies, aseptic processing practices are changing rapidly

Modern therapies add emphasis to the industry-wide need to take advantage of new technologies and explore new ways of addressing process control.

The high risk involved with biopharmaceuticals means there are high demands placed on the hygienic design of bioprocessing equipment.

It would be foolish to underestimate the risk associated with aseptic drug processing

Pharmaceutical and biopharma manufacturers need to move fluids from one cleanroom to another quickly, with maximum productivity and minimal effort and expense.

This new automation and control resource guide covers these topics, and more, in depth

ISPE believes moving to Pharma 4.0 represents a competitive advantage to the extent that not embracing its potential might be a business risk for pharma companies.

Today’s developing environment — coined the Fourth Industrial Revolution and characterized by rapidly evolving and disruptive advances in technology — has created a new and intimidating...

It’s not too late for the pharmaceutical industry to dodge its reputation for being behind other industries in terms of adopting technology.

In this special report, we explore how virtualization can provide significant advantages for deploying process control systems at pharmaceutical plants.

This white paper explains the many different factors — some obvious and some not so obvious — that determine the cost of robot ownership.

Over 70% of potential research participants live >2 hours away from sites, & patient drop-out rates can reach 30% depending on the therapeutic area. The Solution: eConsent Why...

While regulatory compliance is a complex and cumbersome requirement for pharma manufacturers, it is key to ensuring patients receive quality products. Today's ever-increasing ...

At Rite-Hite, we have many solutions for the pharmaceutical industry along with the knowledge and experience to help you address the issues you face with your clean areas. We ...

For the past year, the pharma industry has been in the spotlight, as drugmakers unite to tackle COVID-19.

As more pharma companies look to lower costs, streamline operations, and expand geographical presence, contract manufacturers are increasingly becoming the unsung heroes of pharma...

Outsourcing to contract manufacturers can be a valuable, even critical, option allowing companies to focus their resources and talents on their primary objectives

Drug manufacturers and contract organizations have shared a mutually beneficial relationship for decades in the pharmaceutical industry and will no doubt continue to do so for...

Whether you face challenges like siloed data across multiple departments or addressing specific data security issues or simply feel restricted by the business applications you...

Without the right data management systems in place, data is nothing more than spreadsheets of wasted opportunity for improvement.

Drug manufacturers charged with developing, scaling up or scaling down any process involving crystallization face major challenges, given the industry's current understanding ...

Now more than ever, it is important to protect employees, contractors, and anyone else who accesses your facility's roof. Making rooftop safety a priority at your location can...

Today’s pharmaceutical industry is facing big expectations and opportunities.

For the past year, the pharma industry has been in the spotlight, as drugmakers unite to tackle COVID-19.

The generic and biosimilars industry has positioned itself as the solution to the challenge of skyrocketing health care costs.

Generics step up to the plate, challenges and best practicies for manufacturing biosimilars and excipient trends

The power of simulation in designing a pharmaceutical manufacturing process is due to the unique and detailed information it can provide for many operations. Learn more in this...

There are many factors that can affect medication access and initiation. With the power of AI and predictive analytics, patient support interventions can be optimized to allow...

Digital technology is continuing to play a widening role in the pharma world — at least, for companies willing to begin the transformation

Parenteral drugs are taking a strong position alongside the more established oral solid dose forms and are quickly coming into their own.

Biopharma R&D spending by PhRMA members grew from $2 billion in 1980 to some $51.6 billion in 2013. While no one’s crystal ball can exactly predict where the industry is headed...

In biopharmaceutical development, scale up and scale down are critical to developing a robust process and maintaining product quality. This eBook is a resource for best practices...

“A place for everything, and everything in its place” is the mantra of the 5S method

Pharmaceutical packaging products are getting cleaner, safer, and smarter than ever, and deciding how to choose a supplier requires more thought. Leading producers are laser focused...

Industry survey indicates pharma’s need to move towards a single, connected label management solution.

Once viewed as a mundane part of the business, primary packaging of pharmaceuticals has morphed into a hotbed of creativity.

What if you could achieve faster off-gas composition analysis without sacrificing precision and quality? Learn how to gain improved precision, accuracy, long intervals between...

Dragos's annual ICS/OT Cybersecurity Year in Review provides an overview and analysis of ICS vulnerabilities, global threat activity targeting industrial environments & industry...

Dragos's annual ICS/OT Cybersecurity Year in Review provides an overview and analysis of ICS vulnerabilities, global threat activity targeting industrial environments, and industry...

Want to know how to create a successful tablet? One robust enough to survive the journey from manufacturing to packaging is key. Don't do it correctly, you could have a tarnished...

Oral solid dose drugs — the pharma industry’s most established dosage forms — are cost-effective to manufacture, shelf stable and easy to administer.

Oral solid dose formulations — the pharma industry’s tried-and-true treatment forms — continue to play a pivotal role in the industry’s quest to produce quality, effective treatments...

With more than a century of safe, effective usage, oral solid dose products are a proven pharmaceutical market mainstay. While the dosage form isn’t fading away any time soon,...

While the oral solid dosage form has not seen what OSD subject matter expert Dave DiProspero calls a “silver bullet change,” the sector has continued to stay relevant.

Seeking Agile, Excellent Oral Solid Dose Operations

Over the last several years, pharmaceutical leaders have come to realize that their old ways of supply chain management are vastly inadequate for today’s hard-hitting challenges...

A start-to-finish guide for understanding and evaluating equipment move options.Organizations need to find the move system that will keep their operations moving swiftly, efficiently...

This year in particular, the pressure has been on pharma to keep pace with the ongoing demand for pandemic products, while also meeting the needs of rapidly expanding areas of...

Have you heard? Experts at Mesa Labs wrote the biological indicator chapter in Handbook of Validation in Pharmaceutical Processes, Fourth Edition. Read the second part of their...

Are you working with a pharmaceutical product that requires deep cold storage? Studies have shown that deep cold storage temperatures can introduce risk to the container closure...

Pharmaceutical companies looking to increase cost efficiencies have various considerations to incorporate. Decision-making around effective project management, partnership strategy...

Biotechnology and pharmaceutical industries continue to experience increased pressure on financial performance due to several factors, including a rise in the cost of raw materials...

Hot off the press! Read the last segment of the biological indicators chapter in Handbook of Validation in Pharmaceutical Processes, Fourth Edition by the experts at Mesa Labs...

The pharmaceutical industry is under intense pressure to reduce the environmental harm caused by drug development and manufacturing. Learn about Green Chemistry principles and...

Biological indicator professionals at Mesa Labs contributed to the Handbook of Validation in Pharmaceutical Processes, Fourth Edition. Read the first part of their chapter "Biological...

In the highly regulated pharma industry, technological changes and progress tend to become evident relatively slowly.

Pack your bags and join the editors of Pharma Manufacturing as we examine the state of pharma beyond the borders of the United States, exploring the pluses and minus of different...

Despite the increasing number of injectable biologics, solid dose products are a proven pharmaceutical market mainstay. According to GoodRx data, the top 10 drugs based on monthly...